Search

Your search keyword '"Beeldens, F."' showing total 4 results
Start Over Author "Beeldens, F." Search Limiters Peer Reviewed
4 results on '"Beeldens, F."'

2. Gemtuzumab ozogamicin (Mylotarg®) as single-agent treatment for frail patients 61 years of age and older with acute myeloid leukemia: final results of AML-15B, a phase 2 study of the European Organisation for Research and Treatment of Cancer and Gruppo Italiano Malattie Ematologiche dell'Adulto Leukemia Groups

Author

Amadori, S, Suciu, S, Stasi, R, Willemze, R, Mandelli, F, Selleslag, D, Denzlinger, C, Muus, P, Stauder, R, Berneman, Z, Pruijt, J, Nobile, F, Cassibba, V, Marie, J-P, Beeldens, F, Baila, L, Vignetti, M, and de Witte, T

Published
2005
Full Text
View/download PDF

3. The presence of an HLA-identical sibling donor has no impact on outcome of patients with high-risk MDS or secondary AML (sAML) treated with intensive chemotherapy followed by transplantation: results of a prospective study of the EORTC, EBMT, SAKK and GIMEMA Leukemia Groups (EORTC study 06921)

Author

Oosterveld, M, Suciu, S, Verhoef, G, Labar, B, Belhabri, A, Aul, C, Selleslag, D, Ferrant, A, Wijermans, P, Mandelli, F, Amadori, S, Jehn, U, Muus, P, Zittoun, R, Hess, U, Anak, Ö, Beeldens, F, Willemze, R, and de Witte, T

Published
2003
Full Text
View/download PDF

4. P1212 USE OF BASELINE FIBROSCAN TO PREDICT EFFICACY AND SAFETY OF TREATMENT FOR 1143 PATIENTS IN THE TELAPREVIR EARLY ACCESS PROGRAMME.

Author

Wedemeyer, H., Colombo, M., Strasser, S.I., Ferreira, P.A., Urbanek, P., Fernandez, I., Abdurakhmanov, D., Streinu-Cercel, A., Beeldens, F., Iraqi, W., Demasi, R., Hill, A., Lonjon-Domanec, I., and Moreno, C.

Subjects
*TELAPREVIR, *DRUG efficacy, *MEDICATION safety, *LIVER diseases, *LIVER disease treatment, *PATIENTS, *THERAPEUTICS
Published
2014
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results